MARIA C CONTRERAS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health GARDEN CITY, NY NPI 1497271316

General Payments — all program years on this page

$2,862.33

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 111
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $478.26 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $478.2615

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $210.606
Amgen Inc. $144.991
Currax Pharmaceuticals LLC $45.273
Novo Nordisk AS $32.932
ABBVIE INC. $22.521
Advanced Oxygen Therapy Inc. $21.952

By program year

Program yearAmountRecords
2021 $1,014.1447
2022 $476.3226
2023 $893.6123
2024 $478.2615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089523721 Currax Pharmaceuticals LLC $13.63 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089523723 Currax Pharmaceuticals LLC $16.82 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089523725 Currax Pharmaceuticals LLC $14.82 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100323462 Novo Nordisk Inc $13.64 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100390057 Novo Nordisk Inc $19.29 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106946471 ABBVIE INC. $22.52 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111764630 Advanced Oxygen Therapy Inc. $18.15 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117228187 Amgen Inc. $144.99 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117466759 Advanced Oxygen Therapy Inc. $3.80 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135774172 Lilly USA, LLC $14.12 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135774174 Lilly USA, LLC $22.39 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135805342 Lilly USA, LLC $3.75 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135809973 Lilly USA, LLC $20.05 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135811559 Lilly USA, LLC $124.77 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135834555 Lilly USA, LLC $25.52 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.